Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a major world health concern as the causal agent of COVID-19. Although the impact of COVID19 on systemic immunity in the general population has been well characterized the short-term effects of COVID-19 infection on biomarkers of salivary innate immunity elite-level athletes are unknown. PURPOSE: Therefore, this study aimed to determine whether elite college football athletes had altered biomarkers of salivary immunity following the CDC-recommended 14-day quarantine post-SARS-CoV-2 infection. METHODS: Salivary samples were obtained from fourteen NCAA Division I football players who tested positive for SARS-CoV-2 (n = 14), immediately after CDC-recommended quarantine (average days = 14 ± 2 days) and from sixteen position-matched controls who remained uninfected with SARS-CoV-2. Biomarkers of salivary innate immunity (sIgA and alpha-amylase), antimicrobial proteins (AMPs, i.e., HNP1-3, lactoferrin, LL-37) and lung inflammation (SPA, SPLI, and Neutrophil Elastase-alpha-1-anttrypsin complex) were measured using commercially available ELISAs. An independent student t-test was used to determine significant changes in biomarkers between SARS-Cov-2+ and SARS-CoV-2- groups. RESULTS: Human Neutrophil Defensin 1-3 (HNP1-3) secretion rates were significantly higher in the SARS-Cov-2+ participants compared to the SARS-CoV-2- control group (SARS-CoV-2+: 47,668 pg*min-1 ± 9,907 pg*min-1 vs. SARS-CoV-2-: 19,010 pg*min-1 ± 8,689 pg*min-1; p < 0.05), while remaining within the normal ranges for elite athletes. No other significant differences in AMPs concentrations or secretion rates were observed. CONCLUSION: This suggests that a 14-day quarantine period appears to be sufficient to ensure that athletes’ salivary immunity is not compromised, and athletes are not at risk for lung inflammation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call